Antibacterial of Dibenzo-p-Dioxi-2,8-Dicarboxylic Acid Against Pathogenic Oral Bacteria E. faecalis ATCC 29212 Peptide Pheromones: Quorum Sensing of in vitro and in silico Study

Introduction

Dental caries is the most common oral disease among the population. It is a kind of serious disease that increases the quality of life. The most prevalent cause of this problem is demineralization dental hard tissues that cause a lot of people to lose their teeth.¹ Several factors cause this disease, one kind of bacteria that contribute to oral disease is E. faecalis. It is the main bacteria that cause caries, endodontic infection, peri-implantitis, chronic periodontitis, and failed root canal treatment involving chronic apical periodontitis.^2,3

The E. faecalis is a Gram-positive, nonmotile, commensal member of the gut microbiota and spherical bacteria. These bacteria attend about 90% infection in humans that causes the enterococci group. It is very often found in root canals treated teeth, causes failed endodontic treated teeth, and it has emerged a multidrug resistance such as some strain E. faecalis are resistant rifampicin, erythromycin, and azithromycin.^4–6 The resistance of pathogenic bacteria against antibiotics is a serious problem for the future.⁷ An alternative approach is needed such as finding new modes of the action of novel antibiotics.⁸ One of the solutions to finding the novel antibiotic is a computational approach. Virtual screening is a valuable method to identify the effectiveness of lead compound activity.⁹ With the computational and docking methods, the prediction provided by virtual screening aims the researcher to find the most appropriate set of a compound that has required bioactivity from a natural resource, in a very effective and efficient way.^10,11

The antibiotic treatment eliminates vulnerable bacteria from the bacterial population, leaving resistant bacteria to grow and multiply. In the E. faecalis, acquired elements, including antibiotic resistance genes, are estimated to represent over 25% of its genome. Acquired and intrinsic resistance mean that E. faecalis shows resistance to a variety of antibiotics. Virulence-specific therapeutics could avoid the selective pressure posed by antibiotics. Therefore, alternative anti-virulence therapeutic strategies, such as inhibition of the quorum-sensing system, could be sought to target this opportunistic pathogen.¹²

Quorum-sensing, termed QS, is the way bacteria communicate with each other or each cell which uses specific signals to coordinate population behaviors. Its regulate some process that occurs in the cell or synchrony requirement members in their community, such as biofilm formation and dispersal, virulence factor regulation, competence development, sporulation, and many more.^13,14

Pheromone is a small peptide that acts as signals in mediate of QS in Gram-positive bacteria. These signal peptides regulate a wide array of processes, including many related to host-microbe interaction, and thus many provide novel targets for therapies that interfere with communication to disrupt bacterial infection. The pCF10 is a conjugative plasmid that occurs in the conjugation system of E. faecalis. Some precursors and regulators that occur in this system are PrgQ, PrgX, PrgY, PrgZ, and CcfA.¹⁵

The pCF10 is divided into two types of peptide pheromones, they are cCF10 (the amino acid sequence is LVTLVFV) and iCF10 (the amino acid sequence is AITLIFI). The cCF10 encoded by CcfA on the chromosome, while the iCF10 encoded by PrgQ on the plasmid.^15,16 In pCF10 peptide regulation, the positive conjugation regulated by cCF10, act as an inducer of pCF10 conjugation genes from a donor cell, while negative conjunction is regulated by iCF10, act as inhibitor peptide which represses their expression to avoid self-induction by the endogenous pheromone from the recipient cell. The resected cCF10 activities neutralized by iCF10, in the donor cell, the induction state depends on the ratio cCF10/iCF10.¹⁶ The importation of the mature cCF10 peptide into the cytosol is facilitated by PrgZ.¹⁷ Then, both of mature cCF10 and iCF10 compete for binds to PrgX, the master regulator of conjugation peptide from RNPP (Rap, NprR, PlcR, and PrgX) regulators family. PrgX dimer specifically binds pCF10 at two promoters in plasmid pCF10. The iCF10 stabilizes PrgX tetramer, forming a DNA loop restricting access to RNA polymerase. The cCF10 competes with iCF10 for the binding pocket of PrgX. When cCF10 binds to PrgX, it disrupts the tetramers and eventually releases; dimer binding to DNA promoters allow access of RNA polymerase.¹⁸ There is no extended region of high sequence similarity between PgrX and any other known protein, including the TraA proteins.¹⁹

In therapy and drug development, effectiveness, and safety are an important point to use by humans. So, finding a lead compound and treatment method that give no side effect is needed. Natural products can be an option as a source of the active compound.²⁰ Some plants such as Austroeupatorium inulaefolium, Leoheo domatiophorus Chaowasku, Paramignya trimera (Oliv.) Guillaum and Limnocitrus littoralis (Miq.) Swingle contains an essential oil that has various biological activities including antibacterial, antiviral, antimycotic, and antitrichomonas activities.^21–23 Another potential plant is Sarang Semut (Myrmecodia pendans) or commonly known as ant nests plant is one of Rubiciae family which associated with ants. This epiphytic plant is spread in tropical forests, such as Malay Peninsula, Philippines, Cambodia, Cap York, Solomon Island, Sumatra, Borneo, Toraja, Java, and especially in Papua islands.^24,25 Some Papuan peoples consume M. pendans as traditional medicine by boil dried parts of this plant, like consume tea.

Some therapeutic activity from M. pendans had been reported treating a variety of systemic diseases such as leukemia, heart diseases, tuberculosis, kidney, and prostate dysfunction, various allergies, migraines, rheumatism, hemorrhoid, infection diseases,^26,27 especially the infection that causes dental caries.²⁷ Several compounds that were isolated from M. pendans is a derivate of phenolic compound, and it was reported that some derivates of phenolic compounds had good antibacterial activity, especially against Enterococcus faecalis.^28,29

In this study, it is supposed to give information about a prediction of the drug ability of antibacterial and anti-QS compounds from M. pendans and the prediction of the potential target proteins to which these compounds bind. Furthermore, it is hoped to be a guide for discovering novel antipathogenic agents.

Materials and Methods

The Ligand for this research is a phenolic compound that isolated from Sarang Semut (M. pendans), it was characterized as dibenzo-p-dioxin-2,8-dicarboxylic Acid³⁰ while the positive controls were amoxicillin (CID 33613), ampicillin (CID 6249), enalapril (CID 5388962), and esomeprazole (CID 9568614).³¹ The chemical structure and molecular formula of this ligand retrieved from the PubChem compound database (https://www.ncbi.nlm.nih.gov/pccompound). Some proteins were involved in quorum sensing of E. faecalis was used as a protein target. The protein targets were PrgQ (2grm), prgX (2AW6), PrgZ (4FAJ), and CcfA (YidC) were retrieved from UniProt knowledgebase. (http://www.uniprot.org/).

In silico Characterization of the Compound 1

The phenolic characteristics were confirmed using two online programs. The chemical structures of the Sarang Semut phenolic were drawn again using PubChem Sketcher V2.4 – Mozilla Firefox online to obtain their canonical SMILE. The SMILE for dibenzo-p-dioxin-2,8-dicarboxylic acid was retrieved from the PubChem Compound database.³² Those SMILEs were used to convert the chemical structure into 3D using OPEN BABEL 2.4.1 program, in PDB format.³³ The SMILEs of the phenolic were used further in the prediction of bioactivity. The 3-D structure model of proteins target was build using the SWISS-MODEL server (https://swissmodel.expasy.org/) based on its canonical sequence. The model obtained fitted to the template of the 3-D structure database, PDB entry – 4n0f. This model was in PDB format.³⁴

Molecular Docking Between PgrX/PgrQ/PgrZ/ccfA with Compound 1 and Positive Controls

The ligand-protein docking and virtual screening were performed using Autodock Vina in open source software PyRx 0.8.³⁵ The phenolic compound act as ligands were subject for binding to PrgQ, PrgZ, prgX, and CcfA as protein target; the ligands were free for blind docking. The most favorable free binding energy for the molecular interaction is the one that had a binding energy score that less than 1.0Å in positional root-mean-square deviation (RMSD).³⁶

Complex PgrX/PgrQ/PgrZ/CcfA with Compound 1 and Positive Controls Visualization and Analysis

The docking results were visualized using pymol and then analyzed by software protein plus.^37,38 Pymol showed docking poses and ligand-residue interaction in the 3D molecular picture. To show which residues bind to a ligand, proteins.plus program analyzes the protein-ligand results complex file, and then the picture of molecular interactions come out in 2D structure. For the best visualization, those molecular interactions were showed in the 3D molecular picture.

Results

Refer to the in vitro test, it was known that dibenzo-p-dioxin-2,8-dicarboxylic acid from M. pendans (hereinafter referred to as compound 1) had antibacterial activity against E. faecalis with the inhibition zone was 8.05 mm at in concentration of 1000 μg.mL^−1.30 Some positive controls which had in vitro test were amoxicillin, ampicillin, enalapril, and esomeprazole gave antibacterial activity with their inhibition zones were 16±0.46, 11.5±0.12, 13±0.5 and 17.3±0.53 mm, respectively, with the different concentration about 5–25 μg.mL^−1.31

In this docking process, we used several proteins involved in QS, more precisely in the peptide pheromone signaling process, that known as PrgX, PrgQ, PrgZ dan CcfA/CcfA.⁵ The result of docking showed in Tables 2 and 3.

Table 1 Antibacterial Activity of Compounds from M. pendans and Positive Controls (in vitro Study)

Table 2 Prediction of Antibacterial Activity of Compounds from M. pendans and Positive Controls (in vitro Study)

Table 3 Hydrogen Bond in Protein-Ligand from M. pendans

Discussion

Bioavailability and Antibacterial Activity Prediction of Compound 1 and Positive Controls Through Molecular Interaction with PrgX, PrgQ, PrgZ and CcfA

Based on Table 1, it showed that compound 1 was given higher activity against PrgX and PrgZ than other positive controls with binding affinity value was −9.2 kcal.mol⁻¹ and −7.4 kcal.mol⁻¹, respectively. The highest binding affinity against PgrQ was given from amoxicillin (−7.9 kcal.mol⁻¹), while the highest binding affinity against CcfA was given from amoxicillin and ampicillin (both of them show the binding affinity value −8.3 kcal.mol⁻¹). The active site protein which binds with the compound showed in Table 2. Based on data from Table 2, majority compounds were competitive inhibitor against CcfA proteins binding to Ser240A dan Arg72A (Figure 1). Although the esomeprazole was bound to the Tyr188A site located in the same place with other compounds in CcfA proteins, the esomeprazole is not a competitive inhibitor because it is bind to a different site than other compounds.

Figure 1 Binding site of compound 1 (A), amoxycillin (B), ampicillin (C), enalapril (D), esomeprazole (E) against amino acid residue from CcfA (F) proteins.

The inhibition of CcfA by compounds will certainly prevent the cCF10 leading decrease in cCF10 production.³⁹ If the formation of pCF10 is inhibited, the induction system will be interrupted so that the interaction between bacterial cells are interrupted. In PrgQ, all compound that was tested show their activity with the different binding site that means they were noncompetitive inhibitor against PrgQ. The highest activity against PrgQ showed by amoxicillin with its binding affinity was −7.9 kcal.mol⁻¹ and bond at Arg145A, Ser169A, Lys173A, and Ser170B residue, while a value of binding affinity compound 1 against PrgQ was −6.7 kcal.mol⁻¹ and bond at Asn161B dan Ser275B residue (Figure 2).

Figure 2 Binding site of amoxycillin (A), compound 1 (B), ampicillin (C), enalapril (D), esomeprazole (E) against amino acid residue from PrgQ proteins (F).

Therefore, if there is an inhibition of PrgQ (iCF10 producing) the function of the conjugative precursor inhibition will be inhibited so that the spread of genes throughout the bacterial population becomes uncontrolled. Both of PrgZ and PrgX proteins, all compounds were noncompetitive inhibitor because they were bond at the different sites against the protein, and the highest affinity value was showed by compound 1 with its scores −8.6 kcal.mol⁻¹ and bond to Leu4B, Thr65A, Thr82A. The Gln81A and Val5B residue against PrgZ (Figure 3) and it was −9.2 kcal.mol⁻¹ and bond to Phe59B, Phe59B, Asn63A, and Asn63B residue against PrgX (Figure 4).

Figure 3 Binding site of enalapril (A), compound 1 (B), amoxycillin (C), ampicillin (D), esomeprazole (E) against amino acid residue from PrgZ (F) proteins.

Figure 4 Binding site of enalapril (A), compound 1 (B), amoxycillin (C), ampicillin (D), esomeprazole (E) against amino acid residue from PrgX proteins (F).

In pCF10 regulation, the PrgZ acts as a facilitator in the importing process of peptide signals from plasmid to cytosol. Meanwhile, the PrgX acts as a master regulator that establishes complex with the peptide signal in the cytosol. Therefore, inhibition both of PrgZ or PrgZ will obstruct the main pCF10 regulation process and the QS system will be blocked.

Based on the data, it is obtained that compound 1 has higher activity against PrgX and PrgZ proteins than all positive controls, while the amoxicillin has the highest activity against PrgQ and CcfA proteins. The different activity and binding site from all compounds is suggested by the different structure as follow in Figure 5.

Figure 5 Chemical structure of compounds of dibenzo-p-dioxin-2,8-dicarboxylic acid (A) from M. pendans; positive control: amoxycillin (B), enalapril (C), ampicillin (D), and esomeprazole (E).

Chemical Structure Relationship on Antibacterial Activities of Compound 1 and Positive Controls

Based on the result and the structural comparison of all compound test, it suggests that the existence of carboxyl groups give the most contribute to the activity.⁴⁰ Compound 1 has the most activity because it has two carboxylic acid groups while amoxicillin, ampicillin, and esomeprazole have one carboxylic group, respectively. Even though the amoxicillin and ampicillin have a similar structure, in this case, they have a different activity. The activity of amoxicillin is better than ampicillin’s activity because there is a hydroxyl group of amoxicillin which suggests increasing the activity of its compound.⁴¹

Besides, pheromone inhibitors isolated from bacteria such as iPD1, iAD1, iCF10, and iAM373 have a linear peptide structure. They have a similar characteristic in which the structure of them contains hydrophobic amino acid-like Leu, Phe, Gly, Thr, and Ile that match with the part of pheromone structure.⁴² It could be the same analogy for the interaction of compound 1 and positive control with the protein (pheromone). The part of compound 1 and the positive control structure is hydrophobic alkyl includes phenyl, methyl, etc.

Comparison Between the Result of in vitro and in silico

The in vitro study showed that compound 1 has the lowest of inhibition zone (8.8 mm) while in silico study suggested it has the highest binding affinity against PrgX and PrgZ (−9.2 kcal.mol⁻¹ and −7.4 kcal.mol⁻¹). Difference result from in vitro and in silico methods are cannot be separated from the complexity of biological system factors which cannot be fully represented by a computer program. Moreover, as a nonlinear system, biological entities is also showing ‘screwd up behavior’⁴³

Conclusion

The dibenzo-p-dioxin-2,8-dicarboxylic acid (compound 1) from Sarang semut (Myrmecodia pendans) has a good activity to inhibit Enterococcus faecalis through its peptide pheromones, which cause the existence of its carboxyl groups, or in another word, compound 1 has antibacterial and anti-QS activity. The result of this study can be guidance in advance research including in vitro, in vivo, and trial clinical.